Dan Benjamin Teleman, the Chief Executive Officer of $NSRX, bought 2,900 shares of the company on 04-22-2026 for an estimated $10,904. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 1.9%. Following this trade, they now own 156,991 shares of this class of $NSRX stock.
$NSRX Insider Trading Activity
$NSRX insiders have traded $NSRX stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $NSRX stock by insiders over the last 6 months:
- DAN BENJAMIN TELEMAN (Chief Executive Officer) has made 2 purchases buying 17,900 shares for an estimated $41,504 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NSRX Hedge Fund Activity
We have seen 0 institutional investors add shares of $NSRX stock to their portfolio, and 1 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG removed 863 shares (-69.5%) from their portfolio in Q4 2025, for an estimated $7,896
- MORGAN STANLEY added 0 shares (+0.0%) to their portfolio in Q4 2025, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NSRX Price Targets
Multiple analysts have issued price targets for $NSRX recently. We have seen 2 analysts offer price targets for $NSRX in the last 6 months, with a median target of $18.5.
Here are some recent targets:
- Jason N. Butler from Citizens set a target price of $18.0 on 03/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
